Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3875150)

Published in Tissue Eng Part A on October 02, 2013

Authors

Lenie J van den Broek1, Kim L Kroeze, Taco Waaijman, Melanie Breetveld, Shakun C Sampat-Sardjoepersad, Frank B Niessen, Esther Middelkoop, Rik J Scheper, Susan Gibbs

Author Affiliations

1: 1 Department of Dermatology, VU University Medical Center , Amsterdam, The Netherlands .

Articles citing this

The burn wound exudate-an under-utilized resource. Burns (2014) 0.84

The Role of Chemokines in Mesenchymal Stem Cell Homing to Wounds. Adv Wound Care (New Rochelle) (2015) 0.82

Gingiva Equivalents Secrete Negligible Amounts of Key Chemokines Involved in Langerhans Cell Migration Compared to Skin Equivalents. J Immunol Res (2015) 0.81

Soluble factors from biofilms of wound pathogens modulate human bone marrow-derived stromal cell differentiation, migration, angiogenesis, and cytokine secretion. BMC Microbiol (2015) 0.80

Wharton's jelly mesenchymal stem cells promote wound healing and tissue regeneration. Stem Cell Res Ther (2014) 0.78

The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis. Stem Cells Transl Med (2015) 0.78

Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®)). Clin Cosmet Investig Dermatol (2015) 0.78

Adeno-Associated Virus 5 Transduces Adipose-Derived Stem Cells with Greater Efficacy Than Other Adeno-Associated Viral Serotypes. Hum Gene Ther Methods (2016) 0.75

Development of a Full-Thickness Human Gingiva Equivalent Constructed from Immortalized Keratinocytes and Fibroblasts. Tissue Eng Part C Methods (2016) 0.75

Extensive Characterization and Comparison of Endothelial Cells Derived from Dermis and Adipose Tissue: Potential Use in Tissue Engineering. PLoS One (2016) 0.75

Relationship between p53 gene codon-72 polymorphisms and hypertrophic scar formation following caesarean section. Exp Ther Med (2014) 0.75

TSG-6 Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells Ameliorates DSS-induced colitis by Inducing M2 Macrophage Polarization in Mice. Sci Rep (2017) 0.75

Pro-inflammatory chemokines and cytokines dominate the blister fluid molecular signature in epidermolysis bullosa patients and affect leukocyte and stem cell migration. J Invest Dermatol (2017) 0.75

Stimulation of Oral Fibroblast Chemokine Receptors Identifies CCR3 and CCR4 as Potential Wound Healing Targets. J Cell Physiol (2017) 0.75

Articles cited by this

Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35

Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell (2002) 19.15

Growth factors and cytokines in wound healing. Wound Repair Regen (2009) 7.14

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med (2002) 4.02

Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 3.65

The basic science of wound healing. Plast Reconstr Surg (2006) 3.63

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 3.31

Chemokines in cutaneous wound healing. J Leukoc Biol (2001) 3.19

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A (1999) 3.00

The role of vascular endothelial growth factor in wound healing. J Surg Res (2008) 2.68

Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol (2007) 2.19

Hypertrophic burn scars: analysis of variables. J Trauma (1983) 2.15

Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy (2006) 1.99

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95

Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells (2010) 1.78

Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol (2008) 1.71

Skin tissue engineering--in vivo and in vitro applications. Adv Drug Deliv Rev (2011) 1.39

Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost (1987) 1.25

Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns (2007) 1.21

Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell (2011) 1.21

Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol (1994) 1.17

Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res (2010) 1.12

CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes. Stem Cells (2006) 1.11

Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. J Pathol (2004) 1.10

IFATS collection: Using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells (2008) 1.10

From wound to scar. Burns (1996) 1.06

Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. J Invest Dermatol (2009) 1.04

Microcarriers and their potential in tissue regeneration. Tissue Eng Part B Rev (2010) 1.04

Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen (2007) 1.03

Cellular sources and inducers of cytokines present in acute wound fluid. Wound Repair Regen (2011) 0.99

Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. J Invest Dermatol (2011) 0.96

Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds. PLoS One (2013) 0.94

The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies. J Cell Biochem (1982) 0.94

Hypertrophic scar: a genetic hypothesis. Burns (1990) 0.91

Human adipose-derived stem cells as future tools in tissue regeneration: osteogenic differentiation and cell-scaffold interaction. Int J Artif Organs (2008) 0.88

Collagen cross-linking by adipose-derived mesenchymal stromal cells and scar-derived mesenchymal cells: Are mesenchymal stromal cells involved in scar formation? Wound Repair Regen (2009) 0.87

Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol (2006) 0.86

Autologous skin substitute for hard-to-heal ulcers: retrospective analysis on safety, applicability, and efficacy in an outpatient and hospitalized setting. Wound Repair Regen (2013) 0.82

Comparison of wound closure after burn and cold injury in human skin equivalents. J Invest Dermatol (2006) 0.82

Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol (1995) 0.82

Simple wound exudate collection method identifies bioactive cytokines and chemokines in (arterio) venous ulcers. Wound Repair Regen (2012) 0.81

CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol In Vitro (2005) 0.81

Prostaglandins differentially affect osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. Tissue Eng (2007) 0.81

Use of a collagen-elastin matrix as transport carrier system to transfer proliferating epidermal cells to human dermis in vitro. Cell Transplant (2010) 0.79

Accelerated healing of diabetic wound using artificial dermis constructed with adipose stem cells and poly (L-glutamic acid)/chitosan scaffold. Chin Med J (Engl) (2013) 0.79

Adipose-derived stem cells for skin regeneration. Methods Mol Biol (2011) 0.77

Articles by these authors

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood (2008) 3.65

Intralesional cryotherapy for treatment of keloid scars: a prospective study. Plast Reconstr Surg (2015) 3.26

The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg (2004) 3.14

The Use of Autologous Fat Grafting for Treatment of Scar Tissue and Scar-Related Conditions: A Systematic Review. Plast Reconstr Surg (2016) 3.13

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol (2012) 3.10

Effectiveness of Autologous Fat Grafting in Adherent Scars: Results Obtained by a Comprehensive Scar Evaluation Protocol. Plast Reconstr Surg (2017) 3.04

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res (2002) 2.86

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A (2002) 2.79

Clinical effectiveness of dermal substitution in burns by topical negative pressure: a multicenter randomized controlled trial. Wound Repair Regen (2012) 2.78

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol (2007) 2.47

Potential cellular and molecular causes of hypertrophic scar formation. Burns (2008) 2.39

Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet (2005) 2.36

Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32

High-dose-rate brachytherapy for the treatment of recalcitrant keloids: a unique, effective treatment protocol. Plast Reconstr Surg (2014) 2.05

Macrophages in skin injury and repair. Immunobiology (2011) 2.00

Morphometry of dermal collagen orientation by Fourier analysis is superior to multi-observer assessment. J Pathol (2002) 1.98

Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol (2004) 1.93

MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest (2002) 1.79

Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation. Blood (2011) 1.76

Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective. Exp Dermatol (2014) 1.71

Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol (2002) 1.64

Prevention and curative management of hypertrophic scar formation. Burns (2008) 1.63

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J Immunol (2002) 1.52

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol (2002) 1.49

Costs of burn care: a systematic review. Wound Repair Regen (2014) 1.49

Topical silicone gel versus placebo in promoting the maturation of burn scars: a randomized controlled trial. Plast Reconstr Surg (2010) 1.48

Evidence for subcomplexes in the Fanconi anemia pathway. Blood (2006) 1.43

Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene (2003) 1.39

No efficacy for silicone gel sheeting in prevention of abnormal scar formation in children with cancer: a randomized controlled trial. Plast Reconstr Surg (2015) 1.39

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer (2005) 1.39

"Reply to: Effectiveness of autologous fat grafting in adherent scars: results obtained by a comprehensive scar evaluation protocol". Plast Reconstr Surg (2017) 1.38

ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res (2005) 1.37

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival. Clin Cancer Res (2008) 1.36

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clin Immunol (2010) 1.34

CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer (2007) 1.31

Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients. Clin Cancer Res (2008) 1.24

MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood (2002) 1.21

Scar assessment tools: implications for current research. Plast Reconstr Surg (2002) 1.21

T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment. Cancer Immunol Immunother (2012) 1.19

Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest (2002) 1.19

Colour evaluation in scars: tristimulus colorimeter, narrow-band simple reflectance meter or subjective evaluation? Burns (2004) 1.19

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines. Cancer Immunol Immunother (2008) 1.18

Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia (2004) 1.17

The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. J Immunother (2005) 1.17

Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antivir Ther (2009) 1.16

Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol (2004) 1.16

CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol (2008) 1.15

Biological background of dermal substitutes. Burns (2009) 1.15

Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol (2002) 1.14

Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. Wound Repair Regen (2009) 1.13

Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia (2005) 1.12

Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients. Clin Cancer Res (2007) 1.12

Collagen morphology in human skin and scar tissue: no adaptations in response to mechanical loading at joints. Burns (2003) 1.11

Dendritic cells: biology of the skin. Contact Dermatitis (2009) 1.11

Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. J Pathol (2004) 1.10

Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells. Eur J Cancer (2002) 1.10

Comparison between human fetal and adult skin. Arch Dermatol Res (2009) 1.10

The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2. PLoS One (2009) 1.08

Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside. Nat Clin Pract Rheumatol (2007) 1.08

Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. Cancer Res (2002) 1.08

Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen (2002) 1.06

A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. J Immunol (2006) 1.06

The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol (2004) 1.06

Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia. Clin Cancer Res (2005) 1.05

Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns (2004) 1.05

ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. J Leukoc Biol (2009) 1.05

Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. J Invest Dermatol (2009) 1.04

Expression of the breast cancer resistance protein in breast cancer. Clin Cancer Res (2002) 1.04

Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol (2002) 1.04

Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen (2007) 1.03

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood (2002) 1.03

Human dendritic cell line models for DC differentiation and clinical DC vaccination studies. J Leukoc Biol (2008) 1.03

Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy (2009) 1.02

Structural domains of vault proteins: a role for the coiled coil domain in vault assembly. Biochem Biophys Res Commun (2002) 1.02

Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritis. J Pharmacol Exp Ther (2012) 1.02

Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients. Virchows Arch (2006) 1.01

Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia (2003) 1.01

Dermal substitution in acute burns and reconstructive surgery: a 12-year follow-up. Plast Reconstr Surg (2010) 1.00

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunol Immunother (2006) 1.00

IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells. J Transl Med (2013) 1.00

Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol (2008) 1.00

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells. Cancer Res (2003) 0.99

Detrimental dermal wound healing: what can we learn from the oral mucosa? Wound Repair Regen (2013) 0.99

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors. Exp Hematol Oncol (2013) 0.98

Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma. Cancer Res (2004) 0.98

Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C. J Hepatol (2007) 0.98

Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications. J Urol (2003) 0.98

A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library. J Immunol (2002) 0.98

A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor. J Leukoc Biol (2006) 0.97